Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices

Neuroscience

Volumn 180, Issue , 2011, Pages 238-247

  Berger, F ^a   Hensel, A ^b   Nieber, K ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Glutamate; Kainate; NMDA; Saffron; Synaptic transmission; Trans crocetin

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CROCETIN; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; PLANT EXTRACT; SAFFRON EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CINGULATE GYRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUTAMATERGIC SYNAPTIC TRANSMISSION; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE STEADY POTENTIAL; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CAROTENOIDS; CROCUS; GYRUS CINGULI; MALE; MICROELECTRODES; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PLANT EXTRACTS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC POTENTIALS; SYNAPTIC TRANSMISSION;

EID: 79953198908     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.02.037     Document Type: Article

References (33)

1. Ahmad A.S., Ansari M.A., Ahmad M., Saleem S., Yousuf S., Hoda M.N., Islam F. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 2005, 81:805-813.
2. Akhondzadeh S., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S.S., Yousefi M.H., Alimardani R., Jamshidi A., Rezazadeh S.A., Yousefi A., Zare F., Moradi A., Vossoughi A. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology 2010, 207:637-643.
3. Asai A., Nakano T., Takahashi M., Nagao A. Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J Agric Food Chem 2005, 53:7302-7306.
4. Brand A., Vissiennon Z., Eschke D., Nieber K. Adenosine A1 and A3 receptors mediate inhibition of synaptic transmission in rat cortical neurones. Neuropharmacology 2001, 40:85-95.
5. Cherubini E., North R.A., Williams J.T. Synaptic potentials in rat locus coeruleus neurones. J Physiol 1988, 406:431-442.
6. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
7. Hentschel S., Lewerenz A., Nieber K. Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 2003, 21(1-2):55-63.
8. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994, 17:31-108.
9. Hosseinzadeh H., Talebzadeh F. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 2005, 76:722-724.
10. Hosseinzadeh H., Sadeghnia H.R., Rahimi A. Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic acid treatment in anaesthetized rats. Planta Med 2008, 74:1441-1445.
11. Hosseinzadeh H., Sadeghnia H.R. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 2005, 8(3):394-399.
12. Hosseinzadeh H., Sadeghnia H.R. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids system. Phytomedicine 2007, 14:256-262.
13. Kemp J.A., McKernan R.M. NMDA receptor pathways as drug targets. Nat Neurosci 2002, 5(Suppl):1039-1042.
14. Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res 2006, 20:1023-1035.
15. Lechtenberg M., Schepmann D., Niehues M., Hellenbrand N., Wunsch B., Hensel A. Quality and functionality of saffron: quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and σ σ1 (sigma-1) receptors. Planta Med 2008, 74:764-772.
16. Lewerenz A., Hentschel S., Vissiennon Z., Michael S., Nieber K. A(3) receptors in cortical neurons: pharmacological aspects and neuroprotection during hypoxia. Drug Dev Res 2003, 58(4):420-427.
17. Martina M., Turcotte M.E., Halman S., Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 2007, 578(1):143-157.
18. Nemati H., Boskabady M.H., Ahmadzadef Vostakolaei H. Stimulatory effect of Crocus sativus (saffron) on β2-adrenoceptors of guinea pig tracheal chains. Phytomedicine 2008, 15:1038-1045.
19. Nieber K., Poelchen W., Illes P. Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 1997, 122(3):423-430.
20. Ochiai T., Soeda S., Ohno S., Tanaka H., Shoyama Y., Shimeno H. Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signalling by increasing glutathione synthesis. Neurochem Int 2004, 44:321-330.
21. Ochiai T., Shimeno H., Mishima K., Iwasaki K., Fujiwara M., Tanaka H., Shoyama Y., Toda A., Eyanagi R., Soeda S. Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta 2007, 1770:578-584.
22. Olney J.W., Sharpe L.G. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 1969, 166:386-388.
23. Osmanovic S.S., Shefner S.A. Enhancement of current induced by superfusion of GABA in locus coeruleus neurons by pentobarbital, but not ethanol. Brain Res 1990, 517:324-329.
24. Papandreou M.A., Kanakis C.D., Polissiou M.G., Efthimiopoulosn S., Cordopatis P., Margarity M., Lamari F.N. Inhibitory activity on amyloid-β aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem 2006, 54:8762-8768.
25. Parsons C.G., Danysz W., Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 1998, 11:523-569.
26. Sadeghnia H.R., Cortez M.A., Liu D., Hosseinzadeh H., Snead O.C. Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography. J Pharm Pharm Sci 2008, 11(3):1-14.
27. Saleem S., Ahmad M., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., Ishrat T., Islam F. Effect of saffron (Crocus sativus) on neurobehavioral and neurochemical changes in cerebral ischemia in rats. J Med Food 2006, 9(2):246-253.
28. Schmidt M., Betti G., Hensel A. Saffron in phytotherapy: pharamcology and clinical uses. Wien Med Wochenschr 2007, 157(13-14):315-319.
29. Sichardt K., Vissiennon Z., Koetter U., Brattström A., Nieber K. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A(1)- and GABA(A)-receptors. Phytother Res 2007, 21(10):932-937.
30. Soeda S., Tsuji Y., Ochiai T., Mishima K., Iwasaki K., Fujiwara M., Yokomatsu T., Murano T., Shibuya S., Shimeno H. Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress. Neurochem Int 2004, 45:619-626.
31. Villmann C., Becker C.M. On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 2007, 13(6):594-615.
32. Vissiennon Z., Sichardt K., Koetter U., Brattström A., Nieber K. Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 2006, 72(7):579-583.
33. Zheng Y.Q., Liu J.X., Wang J.N., Xu L. Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res 2007, 1138:86-94.